Zhengtao Jiang

State Key Laboratory Of Discovery And Utilization Of Functional Components In Traditional Chinese Medicine
Shanghai, 201203, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Discovery of a novel chalcone-derived covalent Keap1 binder for mitigating cisplatin-induced mitochondrial dysfunction and nephrotoxicity.

Discovery of a novel chalcone-derived covalent Keap1 binder for mitigating cisplatin-induced mitochondrial dysfunction and nephrotoxicity.

Journal: Redox biology

Published: April 09, 2025

Functional Imaging of CYP3A4 at Multiple Dimensions Using an AI-Driven High Performance Fluorogenic Substrate.

Functional Imaging of CYP3A4 at Multiple Dimensions Using an AI-Driven High Performance Fluorogenic Substrate.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: December 14, 2024

Scopoletin Reactivates Latent HIV-1 by Inducing NF-κB Expression without Global T Cell Activation.

Scopoletin Reactivates Latent HIV-1 by Inducing NF-κB Expression without Global T Cell Activation.

Journal: International journal of molecular sciences

Published: May 06, 2023

Allogeneic gene-edited HIV-specific CAR-T cells secreting PD-1 blocking scFv enhance specific cytotoxic activity against HIV Env+ cells invivo.

Allogeneic gene-edited HIV-specific CAR-T cells secreting PD-1 blocking scFv enhance specific cytotoxic activity against HIV Env+ cells invivo.

Journal: Virologica Sinica

Published: August 30, 2022

FKBP3 Induces Human Immunodeficiency Virus Type 1 Latency by Recruiting Histone Deacetylase 1/2 to the Viral Long Terminal Repeat.

FKBP3 Induces Human Immunodeficiency Virus Type 1 Latency by Recruiting Histone Deacetylase 1/2 to the Viral Long Terminal Repeat.

Journal: mBio

Published: July 20, 2021

HIV-1-Specific CAR-T Cells With Cell-Intrinsic PD-1 Checkpoint Blockade Enhance Anti-HIV Efficacy in vivo.

HIV-1-Specific CAR-T Cells With Cell-Intrinsic PD-1 Checkpoint Blockade Enhance Anti-HIV Efficacy in vivo.

Journal: Frontiers in microbiology

Published: March 22, 2021

Chemokine Receptor CCR2b Enhanced Anti-tumor Function of Chimeric Antigen Receptor T Cells Targeting Mesothelin in a Non-small-cell Lung Carcinoma Model.

Chemokine Receptor CCR2b Enhanced Anti-tumor Function of Chimeric Antigen Receptor T Cells Targeting Mesothelin in a Non-small-cell Lung Carcinoma Model.

Journal: Frontiers in immunology

Published: November 13, 2020

PEBP1 suppresses HIV transcription and induces latency by inactivating MAPK/NF-κB signaling.

PEBP1 suppresses HIV transcription and induces latency by inactivating MAPK/NF-κB signaling.

Journal: EMBO reports

Published: September 20, 2019

Dual effects of the novel ingenol derivatives on the acute and latent HIV-1 infections.

Dual effects of the novel ingenol derivatives on the acute and latent HIV-1 infections.

Journal: Antiviral research

Published: March 02, 2019

Zinc-Finger Nucleases Induced by HIV-1 Tat Excise HIV-1 from the Host Genome in Infected and Latently Infected Cells.

Zinc-Finger Nucleases Induced by HIV-1 Tat Excise HIV-1 from the Host Genome in Infected and Latently Infected Cells.

Journal: Molecular therapy. Nucleic acids

Published: December 12, 2017

The bromodomain and extraterminal domain inhibitor bromosporine synergistically reactivates latent HIV-1 in latently infected cells.

The bromodomain and extraterminal domain inhibitor bromosporine synergistically reactivates latent HIV-1 in latently infected cells.

Journal: Oncotarget

Published: July 12, 2017

BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency.

BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency.

Journal: Scientific reports

Published: June 07, 2017

Showing 1-12 of 16

Last Updated: 09/26/2026